Genetic Signatures are pleased to advise that our application for CE-IVD registration of our EasyScreen™ SARS-CoV-2 Detection Kit was granted overnight (Tuesday 31st March 2020). This allows the kit to be marketed freely in the European Union, and the customers whose kits were already shipped to Europe can start testing once they have finished setting…

Genetic Signatures are pleased to be attending the 6th Joint Conference of the DGHM & VAAM, which encompasses the German Society for Hygiene and Microbiology (DGHM) and the Association for General and Applied Microbiology (VAAM). This will be held in Leipzig (Germany) from 08–11 March 2020. The key topics are big data, microbial physiology and…

Genetic Signatures are pleased to be joining over 700 delegates at the prestigious 19. Klinisch-Mikrobiologisch-Infektiologisches Symposium held at Russisches Haus der Wissenschaft und Kultur in Berlin. “This year’s conference will focus on the topic “Responsible use of diagnostics for the detection and therapy management of infectious diseases” and will for the first time include the…

Last week we were honoured with a visit from our Angel investor and co-founder Chris Abbott. His recent The Australian Financial Review interview alongside our CEO John Melki details his long term interest in Biotech, Molecular Diagnostics and Genetic signatures in particular. We have been lucky to have great investors and advisors to guide our…

Genetic Signatures were pleased to host a lab visit recently by Nobel Laureate and special advisor Sir Gregory Winter and co-founder Chris Abbott. In Sydney to receive a Doctor of Medical Science (honoris causa) from Uni of Sydney for his contributions to science, entrepreneurship and health, Sir Gregory recently retired as Master of Trinity College…

Genetic Signatures’ are proud to announce we will be exhibiting at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 13-16 April 2019 in Amsterdam, Netherlands. Visit our European team at Booth #1.88 where we will showcase our 3baseTM technology and our EasyScreenTM products. Learn more about our syndromic detection kits towards Enteric bacterial,…

Genetic Signatures are exhibiting at Association for Molecular Pathology (AMP) Annual meeting 2018 in San Antonio, Texas 1-3 November. AMP is the leading organization in the field of molecular diagnostics of molecular professionals. The theme of this year’s meeting will be, “Precision Medicine Starts Here”. AMP 2018 is the only educational event developed and presented…

Genetic Signatures EasyScreen™ Pathogen Detection Kits will be featured in an oral presentation at the upcoming National Reference Laboratory (NRL) Workshop on Molecular Diagnostics in Melbourne, Australia. Dr. Damien Stark from St. Vincent’s Hospital Pathology (SydPath) will present “EasyScreen™ Multiplex PCR for STI Infections, a Year in Review.” The aim of this workshop is to…

Genetic Signatures are exhibiting at the 21st ESCV (European Society for Clinical Virology) in Athens, Greece, 23-26 September 2018. The ESCV Annual Meeting has been a major event for the Clinical Virology scientific community and it is becoming more popular, comprehensive, innovative and influential while maintaining high standards of scientific quality and a family atmosphere.…

Since the first Sheffield Microbe in 1986, Sheffield Microbe has provided high quality, value for money, and symposia for local and national Biomedical Scientists. In recent years Microbe has attracted delegates from around the world, and is regularly attended by delegates across Europe. There are currently fifteen committee organisers who organise forthcoming Microbe events. Microbe symposia are held every 2 years. Microbe events…